Mokari Atabak

Track

Insider profile

Mokari Atabak's trades of Corcept Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-30 2026-07-30
PrS Proposed sale
35,823
322.50
US$1,479,852 		35,823 322.50 US$1,479,852
2026-07-17 2026-07-15
PlS Planned sale
38,606 +45.5%
488.21
US$1,053,850 		38,606 +45.5% 488.21 US$1,053,850
2026-07-17 2026-07-15
PlS Planned sale
82,279 +25.4%
387.12
US$1,717,168 		82,279 +25.4% 387.12 US$1,717,168
2026-07-17 2026-07-15
PlS Planned sale
28,460 -59.0%
87.89
US$2,501,244 		28,460 -59.0% 87.89 US$2,501,244
2026-07-17 2026-07-15
PlS Planned sale
7,919 -14.1%
86.78
US$687,179 		7,919 -14.1% 86.78 US$687,179
2026-06-17 2026-06-15
PlS Planned sale
2 -0.0%
82.45
US$165 		2 -0.0% 82.45 US$165
2026-06-17 2026-06-15
PlS Planned sale
19,483 -54.7%
81.81
US$1,593,889 		19,483 -54.7% 81.81 US$1,593,889
2026-06-17 2026-06-15
PlS Planned sale
11,081 -23.7%
80.94
US$896,923 		11,081 -23.7% 80.94 US$896,923
2026-06-17 2026-06-15
PlS Planned sale
9,434 -16.8%
80.02
US$754,924 		9,434 -16.8% 80.02 US$754,924
2026-06-03 2026-06-01
PlS Planned sale
40,000 -72.4%
70.00
US$2,800,004 		40,000 -72.4% 70.00 US$2,800,004
2026-06-01 2026-06-01
PrS Proposed sale
160,000
70.00
US$11,200,016 		160,000 70.00 US$11,200,016